"Pseudotumor Cerebri" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A condition marked by raised intracranial pressure and characterized clinically by HEADACHES; NAUSEA; PAPILLEDEMA, peripheral constriction of the visual fields, transient visual obscurations, and pulsatile TINNITUS. OBESITY is frequently associated with this condition, which primarily affects women between 20 and 44 years of age. Chronic PAPILLEDEMA may lead to optic nerve injury (see OPTIC NERVE DISEASES) and visual loss (see BLINDNESS).
| Descriptor ID |
D011559
|
| MeSH Number(s) |
C10.228.140.631.750
|
| Concept/Terms |
Pseudotumor Cerebri- Pseudotumor Cerebri
- Idiopathic Intracranial Hypertension
- Hypertension, Idiopathic Intracranial
- Intracranial Hypertension, Idiopathic
- Benign Intracranial Hypertension
- Hypertension, Benign Intracranial
- Intracranial Hypertension, Benign
|
Below are MeSH descriptors whose meaning is more general than "Pseudotumor Cerebri".
Below are MeSH descriptors whose meaning is more specific than "Pseudotumor Cerebri".
This graph shows the total number of publications written about "Pseudotumor Cerebri" by people in this website by year, and whether "Pseudotumor Cerebri" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 3 | 0 | 3 |
| 2003 | 1 | 0 | 1 |
| 2006 | 2 | 0 | 2 |
| 2007 | 1 | 0 | 1 |
| 2008 | 1 | 1 | 2 |
| 2009 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2014 | 1 | 1 | 2 |
| 2016 | 1 | 0 | 1 |
| 2018 | 2 | 0 | 2 |
| 2021 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Pseudotumor Cerebri" by people in Profiles.
-
Sweid A, Daou BJ, Weinberg JH, Starke RM, Sergott RC, Schaefer J, Hauge J, Elizabeth C, Chalouhi N, Gooch MR, Herial N, Zarzour H, Jabbour P, Rosenwasser RH, Tjoumakaris S. In Reply: Experience With Ventriculoperitoneal and Lumboperitoneal Shunting for the Treatment of Idiopathic Intracranial Hypertension: A Single Institution Series. Oper Neurosurg (Hagerstown). 2021 11 15; 21(6):E579-E580.
-
Margolis MS, DeBusk AA, Moster ML, Falardeau JM, Eggenberger ER, Sergott RC, Van Stavern GP. Lumbar Puncture for Diagnosis of Idiopathic Intracranial Hypertension in Typical Patients. J Neuroophthalmol. 2021 Sep 01; 41(3):375-378.
-
Sigireddi RR, Lyons LJ, Lee AG. Idiopathic intracranial hypertension in a transgender female. Can J Ophthalmol. 2019 02; 54(1):e35-e38.
-
Gruener AM, Jolly AD, Ellison JMA, Burdon MA. Weighing the Risks and Benefits of Antidepressants in Idiopathic Intracranial Hypertension. J Neuroophthalmol. 2018 03; 38(1):128-129.
-
Tintle SJ, Harper JC, Webster GF, Kim GK, Thiboutot DM. Safe Use of Therapeutic-Dose Oral Isotretinoin in Patients With a History of Pseudotumor Cerebri. JAMA Dermatol. 2016 05 01; 152(5):582-4.
-
Selbst SM. Pediatric emergency medicine: legal briefs. Pediatr Emerg Care. 2014 Aug; 30(8):583-5.
-
Tepper SJ. Idiopathic intracranial hypertension and low CSF pressure headaches. Headache. 2014 Feb; 54(2):387-8.
-
Waisbourd M, Leibovitch I, Goldenberg D, Kesler A. OCT assessment of morphological changes of the optic nerve head and macula in idiopathic intracranial hypertension. Clin Neurol Neurosurg. 2011 Dec; 113(10):839-43.
-
Ney JJ, Volpe NJ, Liu GT, Balcer LJ, Moster ML, Galetta SL. Functional visual loss in idiopathic intracranial hypertension. Ophthalmology. 2009 Sep; 116(9):1808-1813.e1.
-
Wu-Chen WY, Moster ML. The 60th annual meeting of the American Academy of Neurology Chicago, Illinois, April 12-19, 2008. J Neuroophthalmol. 2008 Dec; 28(4):352-7.